Evidence mapPaperPMID 8888584Full record

ReviewJournal of electron microscopy1996

Glucose transporters in the transepithelial transport of glucose.

K Takata

Registry-linked trialAbstract readReview
PubMed Publisher
In one paragraph

Review in Journal of electron microscopy, 1996. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02694263 (A Randomised Controlled Trial for People With Established Type 2 Diabetes During Ramadan), which is not on this map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02694263 phase4completedstarted 2016, after this paper: background citation

A Randomised Controlled Trial for People With Established Type 2 Diabetes During Ramadan: Canagliflozin (Invokana™) vs. Standard Dual Therapy Regimen: The 'Can Do Ramadan' Study

Ran2016Enrolled25Registered outcomes32Posted comparisons0ConditionsDiabetes Mellitus, Type 2ArmsCanagliflozin, Gliclazide, Glimepiride, Pioglitazone, Repaglinide
Open the trial in the graph
3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 101 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. A Review of Coumarins and Coumarin-Related Compounds for Their Potential Antidiabetic Effect.Clinical medicine insights. Endocrinology and diabetes · 2021
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. SGLT2 inhibition in diabetes mellitus: rationale and clinical prospects.Nature reviews. Endocrinology · 2012 · on this map
    Review
  18. Article
  19. The inhibition of lipase and glucosidase activities by acacia polyphenol.Evidence-based complementary and alternative medicine : eCAM · 2011
    Article
  20. Glucose transporter Glut-1 is detectable in peri-necrotic regions in many human tumor types but not normal tissues: Study using tissue microarrays.Annals of anatomy = Anatomischer Anzeiger : official organ of the Anatomische Gesellschaft · 2010
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 2 countries.

K TakataLaboratory of Molecular and Cellular Morphology, Gunma University, Japan.
Gunma University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Glucose transporters are integral membrane proteins that mediate the transport of glucose and structurally-related substances across the cellular membranes. Two families of glucose transporter have been identified: the facilitated-diffusion glucose transporter family (GLUT family), and the NA(+)-dependent glucose transporter one (SGLT family). These transporters play a pivotal role in the transfer of glucose across the epithelial cell layers that separate distinct compartments in the mammalian body. In the small intestine, a Na(+)-dependent glucose transporter, SGLT1, is localized at the apical plasma membrane of the absorptive epithelial cells, whereas a facilitated-diffusion glucose transporter, GLUT2, is at the basolateral membrane of the cells. Similar localization is seen in the kidney proximal tubules in the reabsorption of glucose. For the absorption of fructose in the small intestine, fructose transporter GLUT5 is localized at the apical membrane. The expressed GLUT5 in polarized cultured cells is targeted to the apical membrane, showing that the GLUT5 molecule itself has sufficient information to determine its cellular localization. In the blood-tissue barriers, such as the blood-brain barrier, blood-ocular barrier, and placental barrier, either endothelial or epithelial cell layers constitute the barrier. GLUT1 is abundant at the plasma membrane of these barrier cells, and plays a crucial role in the specific transfer of glucose across the barrier. When the barrier is composed of a two-cell layer, gap junctions connecting them could serve as intercellular channels for glucose transfer in addition to GLUT1. Proper localization of glucose transporters and gap junctions is a prerequisite for the successful transepithelial transport of sugars.

Indexed as

AnimalsBiological Transport, ActiveBlood VesselsEpitheliumGlucoseHumansMicroscopy, ElectronMonosaccharide Transport ProteinsSodiumGlucoseMonosaccharide Transport ProteinsSodium

Identifiers

PMID8888584
OpenAlexW2077298306

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.